Skip to content
  • Saturday, 12 September 2026
  • 5:53 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Long-Term Chlorpyrifos Exposure Linked to 2.5-Fold Increase in Parkinson’s Disease Risk UCLA Researchers Find
Neuroscience & Brain Research

Long-Term Chlorpyrifos Exposure Linked to 2.5-Fold Increase in Parkinson’s Disease Risk UCLA Researchers Find

Rifan Muazin Jul 6, 2026 0

A groundbreaking study led by researchers at UCLA Health has established a definitive link between long-term residential exposure to the…

Read More
Neuroscience & Brain Research

Long-Term Exposure to Agricultural Pesticide Chlorpyrifos Linked to 2.5-Fold Increase in Parkinson’s Disease Risk According to UCLA Health Study

Rifan Muazin Jun 29, 2026 0

A comprehensive investigation led by researchers at UCLA Health has established a definitive and alarming link between long-term residential exposure…

Read More
Advanced Materials Science

Quantum Metasurface Integration Breakthrough Achieves Twenty-Fold Efficiency Gain in Terahertz Radiation Detection

Nila Kartika Wati Jun 1, 2026 0

The detection of electromagnetic radiation across various spectra serves as the backbone of modern technological infrastructure, facilitating everything from fiber-optic…

Read More
Biotech & Genetic Research

Sartorius Unveils Groundbreaking Engineered CHO Cell Line Delivering Up to Three-Fold Productivity Boost for Biotherapeutic Manufacturing

Jia Lissa Apr 24, 2026 0

Sartorius, a prominent international partner for life science research and the biopharmaceutical industry, has announced a significant breakthrough in biotherapeutic…

Read More
Pharmaceutical R&D

The Non-GLP-1 Obesity Drug Market Set for Explosive 50-Fold Growth, Reaching $15.5 Billion by 2031

Teuku Ryan Apr 21, 2026 0

The global pharmaceutical market for obesity treatments is poised for a dramatic transformation, with a burgeoning segment of non-Glucagon-like peptide-1…

Read More
Madrigal Pharmaceuticals Secures Global Rights to Arrowhead’s siRNA Asset for MASH, Paving Way for Combination Therapy ExplorationBlazing new paths for biotechNTU Singapore Scientists Revolutionize Optical Skyrmion Production Using 200-Year-Old Classic Physics ExperimentDeep Ocean Pressure Unlocks Hidden Nutrient Reserves, Rewriting Understanding of Marine Ecosystems and Carbon Cycle
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetLLMOps in 2026: The 10 Tools Every Team Must Have
TWiV 1287: Ancient herpesviruses and modern dementiaJohns Hopkins Researchers Discover How Fusion Genes Drive Rare Kidney Cancer Through Liquid DropletsRNA breakthrough provides hope for thousands of untreatable diseases, including cystic fibrosis, muscular dystrophy and some cancersMerck and Moderna’s cancer vaccine is customized for each patient’s tumor
YOU MAY HAVE MISSED
Microbiology & Immunology
TWiV 1287: Ancient herpesviruses and modern dementia
Lina Irawan Sep 12, 2026
Stem Cell & Regenerative Medicine
Johns Hopkins Researchers Discover How Fusion Genes Drive Rare Kidney Cancer Through Liquid Droplets
Dwi Wanna Sep 12, 2026
Biotech & Genetic Research
RNA breakthrough provides hope for thousands of untreatable diseases, including cystic fibrosis, muscular dystrophy and some cancers
Jia Lissa Sep 12, 2026
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Sep 12, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ